257 related articles for article (PubMed ID: 11303037)
1. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
[TBL] [Abstract][Full Text] [Related]
2. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
[TBL] [Abstract][Full Text] [Related]
3. Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology.
Bolchoz LJ; Morrow JD; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2002 Oct; 303(1):141-8. PubMed ID: 12235244
[TBL] [Abstract][Full Text] [Related]
4. Primaquine-induced hemolytic anemia: formation of free radicals in rat erythrocytes exposed to 6-methoxy-8-hydroxylaminoquinoline.
Bolchoz LJ; Gelasco AK; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2002 Dec; 303(3):1121-9. PubMed ID: 12438535
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
[TBL] [Abstract][Full Text] [Related]
6. Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine.
Bowman ZS; Morrow JD; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2005 Aug; 314(2):838-45. PubMed ID: 15840764
[TBL] [Abstract][Full Text] [Related]
7. Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes.
Bowman ZS; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2005 Dec; 315(3):980-6. PubMed ID: 16099929
[TBL] [Abstract][Full Text] [Related]
8. Role of oxidant stress in lawsone-induced hemolytic anemia.
McMillan DC; Sarvate SD; Oatis JE; Jollow DJ
Toxicol Sci; 2004 Dec; 82(2):647-55. PubMed ID: 15456924
[TBL] [Abstract][Full Text] [Related]
9. Role of aniline metabolites in aniline-induced hemolytic anemia.
Harrison JH; Jollow DJ
J Pharmacol Exp Ther; 1986 Sep; 238(3):1045-54. PubMed ID: 3746658
[TBL] [Abstract][Full Text] [Related]
10. Methemoglobin incites primaquine toxicity through single-electron oxidation and modification.
Balaji SN; Trivedi V
J Basic Clin Physiol Pharmacol; 2013; 24(2):105-14. PubMed ID: 23412873
[TBL] [Abstract][Full Text] [Related]
11. The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia.
Jensen CB; Jollow DJ
Toxicol Appl Pharmacol; 1991 Oct; 111(1):1-12. PubMed ID: 1949026
[TBL] [Abstract][Full Text] [Related]
12. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.
Grossman SJ; Jollow DJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):118-25. PubMed ID: 3335994
[TBL] [Abstract][Full Text] [Related]
13. Effects of an NADPH-generating system on primaquine degradation by hamster liver fractions.
Abu-El-Haj S; Allahyari R; Chavez E; Fraser IM; Strother A
Xenobiotica; 1988 Oct; 18(10):1165-78. PubMed ID: 3242312
[TBL] [Abstract][Full Text] [Related]
14. Side-chain hydroxylation in the metabolism of 8-aminoquinoline antiparasitic agents.
Idowu OR; Peggins JO; Brewer TG
Drug Metab Dispos; 1995 Jan; 23(1):18-27. PubMed ID: 7720521
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of a candidate 8-aminoquinoline antimalarial agent, WR 238605, by rat liver microsomes.
Idowu OR; Peggins JO; Brewer TG; Kelley C
Drug Metab Dispos; 1995 Jan; 23(1):1-17. PubMed ID: 7720510
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
Marino MT; Peggins JO; Brown LD; Urquhart MR; Brewer TG
Drug Metab Dispos; 1994; 22(3):358-66. PubMed ID: 8070311
[TBL] [Abstract][Full Text] [Related]
17. [Study on structure-activity relationships of hemolytic toxicity of primaquine derivatives].
Ni YC; Xu YQ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(3):173-7. PubMed ID: 1959168
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism of the antimalarial agent primaquine by mouse liver enzymes and identification of a methemoglobin-forming metabolite.
Strother A; Allahyari R; Buchholz J; Fraser IM; Tilton BE
Drug Metab Dispos; 1984; 12(1):35-44. PubMed ID: 6141909
[TBL] [Abstract][Full Text] [Related]
19. Role of lipid peroxidation in dapsone-induced hemolytic anemia.
McMillan DC; Jensen CB; Jollow DJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):868-76. PubMed ID: 9864266
[TBL] [Abstract][Full Text] [Related]
20. Dapsone-induced hematologic toxicity: comparison of the methemoglobin-forming ability of hydroxylamine metabolites of dapsone in rat and human blood.
Vage C; Saab N; Woster PM; Svensson CK
Toxicol Appl Pharmacol; 1994 Dec; 129(2):309-16. PubMed ID: 7992320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
